ANDA 60768, held by Hikma. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 60768 (Tetracycline Hydrochloride), held by Hikma, was first approved by FDA on Nov 7, 1977, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 7, 1977 | Original application | Approved | None posted |
| Tetracycline Hydrochloride250MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Tetracycline Hydrochloride500MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Mar 31, 2025 | Supplement 2Labeling · Standard review | Approved | None posted |
| Mar 20, 2025 | Supplement 1Labeling · Standard review | Approved | None posted |
| Nov 7, 1977 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters